| 1 |
30222017 | A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas. | 2019 Jun |
1 |
| 2 |
30288799 | Position statement: topical calcineurin inhibitors in atopic dermatitis. | 2018 Dec |
1 |
| 3 |
24811606 | An update on current pharmacotherapy options in atopic dermatitis. | 2014 Aug |
1 |
| 4 |
24973091 | Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells. | 2014 Sep |
1 |
| 5 |
23328499 | [Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. | 2013 |
2 |
| 6 |
21964739 | uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma. | 2012 Mar |
1 |
| 7 |
20678096 | The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis. | 2010 Sep-Oct |
1 |
| 8 |
19400811 | Short-term efficacy of tacrolimus ointment and impact on quality of life. | 2009 Jun |
1 |
| 9 |
17854353 | The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. | 2007 Nov |
1 |
| 10 |
17076660 | Neuroprotectant FK506 inhibits glutamate-induced apoptosis of astrocytes in vitro and in vivo. | 2006 Nov |
1 |